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ABSTRAK
Peningkatan ekspresi dan aktiviti enzim 11β-hidroksisteroid dehidrogenase jenis 
1 (11β-HSD1) di dalam sel adiposit matang menyebabkan obesiti dan sindrom 
metabolik. Fruktos dalam air minuman telah terbukti boleh menyebabkan sindrom 
metabolik pada tikus Wistar jantan. Oleh itu, kajian ini dilakukan untuk melihat 
kesan ke atas ekspresi dan aktiviti enzim 11β-HSD1 di dalam hati model tikus 
sindrom metabolik yang dirangsang dengan air minuman fruktos. Sebanyak 12 ekor 
tikus Wistar jantan dibahagikan secara rawak kepada dua kumpulan: kumpulan 
kawalan, C (n=6) dan kumpulan yang diberi minuman fruktos 20%, F20 (n=6). 
Pemberian makanan dan air minuman selama lapan minggu secara ad libitum. Di 
akhir kajian, pengukuran ekspresi enzim 11β-HSD1 di dalam hati dilakukan dengan 
menggunakan teknik pewarnaan imunohistokimia. Skor diberikan berdasarkan 
intensiti pewarnaan granul di dalam sitoplasma hepatosit menggunakan teknik 
‘double-blinded’. Manakala, aktiviti enzim 11β-HSD1 diukur menggunakan teknik 
ELISA. Selepas lapan minggu pengambilan air minuman fruktos, kumpulan F20 
menunjukkan peningkatan dalam ekspresi dan aktiviti enzim 11β-HSD1 di dalam 
hati. Data yang diperolehi menunjukkan bahawa enzim 11β-HSD1 di dalam 
hati mungkin memainkan peranan dalam pembentukan sindrom metabolik dan 
komplikasinya pada tikus Wistar jantan.
Kata kunci: 11β-hidroksisteroid dehidrogenase, fruktos, sindrom metabolik, tikus 
Wistar
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are striking resemblances between 
these two conditions. In contrast to 
Cushing’s disease, plasma cortisol 
tends to be normal or lower in 
MetS. Nevertheless, rodent obesity 
models showed glucocorticoid 
plays an important role in the 
metabolic disease. The glucocorticoid 
reactivation is mediated by the 
enzyme known as 11β-hydroxysteroid 
dehydrogenase (11β-HSD). Amelung 
and his colleagues discovered the 
11β-hydroxysteroid dehydrogenase 
enzyme (11β-HSD) in 1953 (Morton 
& Seckl 2008). This enzyme converts 
the inactive glucocorticoid hormone 
to active glucocorticoid hormone. 
Cortisone is an inactive form of 
glucocorticoid in human meanwhile 
ABSTRACT
Excessive expression and activity of 11β-hydroxysteroid dehydrogenase enzyme 
type 1 (11β-HSD1) enzyme in mature adipocyte leads to obesity and metabolic 
syndrome. Fructose in drinking water was proven to induce metabolic syndrome in 
male Wistar rat. Hence, the aim of the study was to assess the effects of expression 
and activity of 11β-HSD1 enzyme in the liver in an established metabolic syndrome 
rat model induced by fructose drinking water. Twelve male Wistar rats were 
randomly divided into two groups: Control group, C (n=6) and Fructose drinking 
water 20%, F20 (n=6). The food and fluid intake were given as ad libitum for eight 
weeks. At the end of the experiment, the expression of 11β-HSD1 enzyme in the 
liver was measured by immunohistochemical staining method. The score was 
given according to the intensity of the staining of the granules in the hepatocyte 
cytoplasm which was measured using double-blinded method. Meanwhile, the 
activity of 11β-HSD1 enzyme in the liver was measured using ELISA technique. 
Following eight weeks of consumption of fructose drinking water, the F20 group 
showed an increased in both expression and activity of 11β-HSD1 in the liver. The 
obtained data clearly suggest that 11β-HSD1 enzymes in the liver may play a role in 
the development of metabolic syndrome and its complications in male Wistar rat.
Keywords: 11β-hydroxysteroid dehydrogenase, fructose, metabolic syndrome, Wistar 
rat
INTRODUCTION
Metabolic syndrome (MetS) is a 
constellation of medical conditions 
consisting of central obesity, 
hyperglycemia, hypertension, and 
dyslipidemia. Based on a joint interim 
statement, a person is diagnosed to 
have MetS with at least three of these 
conditions. The prevalence suffered 
by MetS is growing worldwide. It 
is associated with the increased 
morbidity and mortality following its 
complications which include heart 
disease (Kim et al. 2010). Previous 
studies suggested that consumption of 
fructose leads to the development of 
MetS (Elliott et al. 2002).
 Though MetS may share the same 
features as Cushing’s disease, there 
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11-dehydrocorticosterone in rodents. 
Cortisol and corticosterone is the active 
form of glucocorticoid in human and 
rodents respectively (Cooper &  Stewart 
2009). The activity of 11β-HSD in cell 
and tissue was first explained by Monder 
and White in 1993 (Seckl et al. 2004). In 
1980, Monder observed the activity of 
this enzyme in the liver was involved in 
the process of conversion of cortisone 
to cortisol by 11β-reductase (11β-OR) 
as well as conversion of cortisone to 
cortisol by 11β-dehydrogenase (11β-
DH). Apart from liver, this enzyme was 
also found in placenta (Popovici et al. 
2006) and kidney (Schnackenberg et al. 
2013).
 There are two isozymes of 
11β-HSD which are 11β-HSD type 
1 (11β-HSD1) and 11β-HSD type 2 
(11β-HSD2). Both these enzymes 
are involved in the interconversion 
of active glucocorticoid to inactive 
glucocorticoid. Glucocorticoid 
hormones involved in stress 
adaptation, metabolism regulation and 
response to inflammation (Opperman 
2006). The differences between these 
two isozymes are the co-factors, affinity 
and reaction of conversion (Draper & 
Stewart 2005). The 11β-HSD1 enzyme 
was discovered earlier than that of 
11β-HSD2 enzyme (Seckl et al. 2004). 
This enzyme plays an important role in 
the liver and it is also involved in the 
development of obesity (Masuzaki et al. 
2001), dyslipidemia (Cooper & Stewart 
2009) and hyperglycemia (Andrews & 
Walker 1999). The 11β-HSD1 enzyme 
is widely distributed and dependent 
on nicotinamide adenine dinucleotide 
phosphate (NADPH) as a cofactor. 
This enzyme has bi-directional action 
which acts as reductase (11β-OR) and 
dehydrogenase (11β-DH) (Opperman 
2006). However, the function as 11β-
OR is more dominant compared to 
11β-DH. The 11β-HSD1 is widely 
expressed in human (Ricketts et al. 
1998) and rodents (Moisan et al. 
1990) including the liver (Bellemare 
et al. 2006), adipose tissue (Bujalska 
et al. 1997), lungs (Hundertmark et al. 
1993), skeletal muscle, heart muscle 
and smooth muscle (Walker et al. 
1991), anterior pituitary gland and brain 
(Moisan et al. 1990) and adrenal cortex 
(Shimojo et al. 1996). All these sites have 
glucocorticoid receptors except the 
heart and hippocampus (Whorwood et 
al. 1992).
 Research studies showed the 
expression of 11β-HSD1 enzyme 
was mostly around the central vein 
and reduced radially (Brereton et al. 
2001). The presence of expression of 
11β-HSD1 enzyme on the adipose tissue 
and liver explained the pathogenesis of 
development of adiposity, carbohydrate 
metabolism and insulin sensitivity 
(Masuzaki et al. 2001). The development 
of central obesity was related to the 
11β-HSD1 enzyme as shown by its 
expression which was higher in visceral 
adipose tissue than in subcutaneous 
adipose tissue (Bujalska et al. 1997). 
The activity of this enzyme induces 
the differentiation of pre-adipocyte to 
adipocyte by glucocorticoid hormone 
thus, leading to the development of 
central obesity (Cooper &  Stewart 
2009). Another research has showed 
that excessive expression of 11β-HSD1 
enzyme in mature adipocyte leading 
to the development of metabolic 
syndrome which presented with central 
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obesity, dyslipidemia and insulin 
sensitivity (Masuzaki et al. 2001).
 To the best of our knowledge, there 
are limited studies on the expression 
and activity of 11β-HSD1 enzyme in 
the liver in MetS rat model following 
consumption of fructose drinking 
water. Therefore, the results of this 
study may contribute opportunities 
for development of therapeutic 
interventions through 11β-HSD1 
inhibitor in the MetS area.
MATERIALS AND METHODS
PREPARATION OF FRUCTOSE IN 
DRINKING WATER
Pure fructose >99% (Syarikat Systerm 
Malaysia) was used. The preparation of 
fructose drinking water (FDW) was done 
fresh every alternate day (Sánchez-
Lozada et al. 2007) and based on 
weight/volume formula (Shahraki et al. 
2011). To prepare fructose 20% drinking 
water, 20 gm of fructose was diluted in 
100 mL of tap water. The bottles were 
then covered with aluminium foil to 
prevent fermentation (Abdulla et al. 
2011). The FDW was given daily for 
eight weeks as ad libitum.
ANIMAL PREPARATION
All procedures were carried out in 
accordance with the institutional 
guidelines for animal research of 
the Universiti Kebangsaan Malaysia 
(UKMAEC FP/ANAT/2012/FARIHAH/18-
JULY/453-JULY-2012-AUGUST-2013). 
Twelve male Wistar rats weighing 
between 200 and 300g were housed 
individually in a temperature controlled 
room (24oC) with adequate ventilation 
and illuminated for 12 hrs daily (lights 
on from 0700 to 1900) with free access 
to standard rat chow (Gold Coin, Klang, 
Selangor, Malaysia) and tap water ad 
libitum. The rats were acclimatised 
for 1 week. The rats were randomly 
divided into two groups. Each group 
comprised six rats.  The F20 group was 
given 20% fructose in drinking water 
while the Control group (C) received 
only tap water.
EXPERIMENTAL PROTOCOL
After eight weeks, the rats were 
sacrificed by diethyl ether inhalation 
(Ahmad et al. 2011). The liver of 
each rat was sampled into 1-mm 
cubes and fixed immediately in 10% 
formalin for 48 hrs to measure the 
expression of the enzyme by using the 
immunohistochemical (IHC) staining. 
The liver samples were sectioned into 
approximately 1gm weight and was 
immediately covered with aluminium 
foil and kept in the refrigerator at -70˚C 
for measurement of the activity of the 
11β-HSD.  
EXPRESSION OF 11β-HSD1 
ENZYME IN LIVER
The immunohistochemical staining 
was performed with LSAB-2 HRP 
system. After fixation with formalin 
10% and processed, the liver samples 
were sectioned at 5 µm and placed on 
a silanized glass slide and kept dry for 
24 hrs. Then, the liver tissues on the 
slides underwent dewaxing with xylene 
and rehydrated with series of alcohol 
to water. The antigen was retrieved by 
placing the slides in the antigen retrieval 
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solutions. The endogenous peroxidase 
activity was blocked with peroxidase 
blocking solution containing H2O2. 
The sections were then incubated 
with primary antibody. To abolish 
cross-reactivity, the biotinylated 
LINK was placed on the sections. 
Then, the sections were incubated 
with streptavidin conjugated with 
horseradish peroxidase (streptavidin-
HRP) and followed by incubation with 
substrate chromogen solution. Finally, 
the sections were counterstained with 
Mayer’s Hematoxylin and dehydrated 
with series of alcohol followed by 
dewaxed with xylene. The slides were 
then mounted with DPX and viewed 
under light microscope.
 The measurements of the expression 
of the enzymes were measured 
qualitatively under light microscope 
under magnification x20. The 
immunopositive cells were observed 
around the central vein. The score 
was given according to the intensity 
of the staining of the granules in the 
hepatocyte cytoplasm. Score 0 was 
given if there was no staining, score 1 
for weak intensity staining followed by 
score 2 with mild intensity staining and 
final score 3 with the highest intensity 
of the staining of the granules. The 
scoring was done using double-blinded 
method (Haque et al. 2006).
ACTIVITY OF 11β-HSD1 ENZYME 
IN LIVER
The liver samples were first kept cooled 
under room temperature. The sample 
was then put in the 10 mL test tube 
with 5 ml of phosphate buffer solutions 
(PBS) added. The homogenization 
process was done in ice. The samples 
were then centrifuged at 1000 rpm at 
4˚C for 10 mins. The top layer of the 
solutions was taken and placed in 
appendorf  tube for further analysis.
 The measurement of the activity of 
11β-HSD1 in the liver was performed 
using the ELISA kit. All ELISA kit 
components and samples were taken 
out from refrigerator and kept under 
room temperature just before used. 
The procedure were done according 
to the company standard procedure. 
For the assay procedure, determination 
of diluted standard wells, blank 
and samples were done. Wells with 
standard, blank and samples were 
added with 100 µl of dilution. Then, 
removal of water was done following 
two hours of incubation at 37°C. Each 
well was added with 100 µl Detection 
Reagent ‘A’ working solution. Again, 
incubation of the kit was done for 
1 hr at 37°C. Following incubation, 
350 µl wash solution were used to 
wash the kit for 3 times. The kit was 
keep for incubation for 30 mins at 
37°C following adding the 100 µl of 
Detection Reagent B working solution 
to each well. Then it was washed for 
5 times. Subsequently,each well was 
added with  90 µl of Substrate Solution 
and followed by incubation for 20 mins 
at 37°C. Then, each well was added 
with 50 µl of Stop Solution. 
 Finally, the reading of the 
enzymes activity were done by using 
spectrophotometry technique at 450 
nm wave on microplate reader. The 
values of optic density (O.D) were 
taken as a value of the activity of the 
enzyme.
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STATISTICAL ANALYSIS
All data were tested for normal 
distribution and presented as 
Mean±standard error of mean (SEM). 
The comparisons between groups were 
analysed by a one-way Analysis of 
Variance (ANOVA) followed by Tukey 
test for multiple group comparisons. 
The level of significance was taken as 
p < 0.05. All statistical analysis was 
conducted using SPSS version 20 
software. 
RESULTS 
EXPRESSION OF 11β-HSD1 
ENZYME IN LIVER
The immunohistochemical staining to 
measure the expression of the enzyme 
was shown in Figure 1. The granules 
of 11β-HSD1 in the hepatocytes 
cytoplasm were stained brown which 
was highest around the central vein and 
reduced radially in all the three groups. 
In the group that was given fructose in 
drinking water showed greater intensity 
of discoloration around the central 
vein as compared to the C group. The 
statistical analysis showed that the 
scoring was significantly higher in F20 
compared to C group (Figure 2A). 
ACTIVITY OF 11β-HSD1 ENZYME 
IN LIVER
Following consumption of fructose 
in drinking water for eight weeks, the 
activity of 11β-HSD1 enzyme in the 
liver was significantly increased in F20 
group compared to C group (Figure 2B). 
DISCUSSION
The 11β-HSD enzyme was first 
discovered by Amelung and his friends 
in 1953 (Seckl et al. 2004). This enzyme 
involved in conversion of inactive 
glucocorticoid which is cortisone (in 
human) and 11-dehydrocorticosterone 
(in rats) to active glucocorticoid which 
is cortisol (in human) and corticosterone 
(in rats) (Cooper & Stewart 2009). The 
activity of 11β-HSD enzyme in cells and 
tissues was first described by Monder 
and White in 1993 (Seckl et al. 2004). 
There is activity of this enzyme in the 
liver and it is involved in conversion 
of cortisol to cortisone by 11β-(DH) 
as well as conversion of cortisone to 
Figure 1: Immunohistochemical of liver to visualize the expression of 11β-HSD1 enzyme. The 
granules of 11β-HSD1 enzyme in the hepatocyte cytoplasm were stained brown by chromogen 
substrate DAB. The staining was highest around the central vein and reduced radially.
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cortisol by  11β-(OR). Thus, it has been 
postulated that this enzyme is involved 
in the pathway of glucocorticoid. The 
excess of glucocorticoid can lead to 
the differentiation of the adipocytes 
(Hauner et al. 1987; Hauner et al. 
1989). This differentiation is mediated 
by 11β-HSD1 enzyme. Hence, the long 
term usage of glucocorticoid may cause 
MetS (Asensio et al. 2004; Rosmond 
2005).
 The expression of 11β-HSD1 is 
also widely distributed in human and 
rodents tissues including liver (Ricketts 
et al. 1998; Moisan et al. 1990). Having 
the knowledge that this enzyme is 
present in the liver, prompted us to 
study the effect of FDW on 11β-HSD1 
in liver. Research done by Brereton et 
al. (2001) on expression of 11β-HSD1 in 
the liver by using immunohistochemical 
technique has showed that the 
concentrations of the enzyme is highest 
around the central vein and reduced 
radially.
 The present study was done using 
the full blown MetS rat model induced 
by fructose drinking water for eight 
weeks (Mamikutty et al. 2014).  To 
utter surprise, the results indicated that 
with consumption of 20% fructose 
in drinking water for eight weeks had 
increased the expression as well as the 
activity of 11β-HSD1 enzyme in the 
liver. The distribution of this enzyme 
was consistent with previous study 
which was highly distributed around 
the central vein and reduced radially 
(Brereton et al. 2001).  
 There are three mechanisms that we 
hypothesized for the development of 
MetS following consumption of fructose 
in drinking water. Firstly, consumption 
of fructose does increase the caloric 
intake, secondly by the increment of 
expression and activity of 11β-HSD1 
enzyme and lastly by the lipogenic 
property of fructose.
 Consumption of fructose drinking 
water for eight weeks in male Wistar 
rats does increase the total caloric 
intake (Mamikutty et al. 2014). Hence, 
more calories were kept in the form 
of triglyceride (TG). Triglycerides are 
stored in the adipose tissue and act 
as an energy reservoir (Zhou & Qin 
Figure 2: The graph bar of expression of 11β-HSD1 enzyme (A) and the activity of 11β-HSD1 enzyme 
(B) showed statistically significant difference between F20 compared to C. # significant compared 
to C, p<0.05.
63
11β-Hydroxysteroid Dehydrogenase Enzyme in Metabolic Syndrome Med & Health Jun 2017;12(1): 56-65
2012). The storage of TG in adipose 
tissue increased the deposition of 
adipose tissue in the abdomen and thus 
formed the central obesity. In obesity, 
the adipose tissue tends to expand 
(Zhou & Qin 2012). The abdominal 
adipose tissue is the important 
component in the development of 
dyslipidemia, hyperglycemia and 
hypertension (Kershaw & Flier 2004). 
Hypertriglyceridaemia causes reduced 
insulin sensitivity which leads to the 
development of hyperglycaemia.
 The abdominal adipose tissues also 
activate the sympathetic nervous system 
(SNS) and renin angiotensin (Kotsis 
et al. 2010) and it is able to compress 
the kidney (Davy & Hall 2004). These 
lead to the increase of the cardiac 
output (CO) and further hypertension. 
Angiotensinogen which is formed 
by adipose tissue is converted to 
angiotensin I. The angiotensin converting 
enzyme converts the angiotensin I 
to angiotensin II. Angiotensin II is a 
potent vasoconstrictor as well as causes 
retention of sodium and water, thus 
resulting in hypertension.
 Apart from increased calorie intake 
by consumption of fructose drinking 
water, the development of MetS 
might also be established through 
excessive expression and activity of 
11β-HSD1 enzyme in liver. Previous 
studies showed that differentiation of 
pre-adipocyte to mature adipocyte 
by 11β-HSD1 enzyme resulted in the 
development of central obesity (Rabbitt 
et al. 2002). The mature adipocyte 
underwent hypertrophy, which leads 
to obesity (Yau et al. 1995; Tomlinson 
& Stewart 2001). In our study, we 
showed that following consumption 
of FDW resulted in hypertrophy of 
central adipocytes in obese Wistar 
rats (Mamikutty et al. 2014). Excessive 
fat will initially accumulate in adipose 
tissue, followed by the deposition 
in ectopic organs such as liver and 
heart (Britton & Fox 2011). Thus, it 
may lead to the complication of MetS 
which include non-alcoholic fatty liver 
disease  (NAFLD). This condition can 
deteriorate further to liver cirrhosis and 
liver carcinoma. Consumption of FDW 
20% in male Wistar rat has proven to 
cause NAFLD stage 1 (Mamikutty et al. 
2015).
 In the development of 
dyslipidemia, the conversion 
of 11-dehydrocorticosterone to 
corticosterone induces the process of 
lipogenesis (Cooper & Stewart 2009). 
Thus, more lipids are formed and 
increasing the triglyceride (TG) level, 
thereby leading to hypertriglyceridemia. 
The 11β-HSD1 enzyme also plays a 
role in the development of diabetes 
mellitus and insulin resistance (Andrew 
& Walker 1999). The conversion 
of 11-dehydrocorticosterone to 
corticosterone by 11β-HSD1 enzyme 
resulted in gluconeogenesis hence 
causing hyperglycemia. This is 
consistent with our previous result that 
proved consumption of FDW20% for 
eight weeks leads to hyperglycemia in 
Wistar rats (Mamikutty et al. 2014).
CONCLUSION 
In summary, we observed an increase 
in the expression and activity following 
FDW consumption suggesting the 
involvement of 11β-HSD1 enzyme in the 
possible mechanism of development of 
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MetS in male Wistar rat. The limitation 
in our study was the lack of details in 
the molecular level concerning the 
11β-HSD1 enzyme related with obesity 
and metabolic syndrome. Further 
study is required to investigate at the 
molecular level to further explain the 
detailed pathway involved in this MetS 
rat model.
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